Published in Dig Dis Sci on June 01, 1995
Oxidative stress is more important than acid in the pathogenesis of reflux oesophagitis in rats. Gut (2001) 1.90
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus. Gut (2006) 1.58
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer (1999) 1.22
Ameliorative effects of Panax quinquefolium on experimentally induced reflux oesophagitis in rats. Indian J Med Res (2012) 1.22
Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol (2010) 1.20
Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr (2007) 1.03
Efficacy of medical therapy and antireflux surgery to prevent Barrett's metaplasia in patients with gastroesophageal reflux disease. Ann Surg (2001) 1.02
Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. World J Gastroenterol (2005) 0.99
Plasma and esophageal mucosal levels of vitamin C: role in the pathogenesis and neoplastic progression of Barrett's esophagus. Dig Dis Sci (2004) 0.93
The Inhibitory Effect of Quercetin-3-O-beta-D-Glucuronopyranoside on Gastritis and Reflux Esophagitis in Rats. Korean J Physiol Pharmacol (2009) 0.91
The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J Gastroenterol (2016) 0.88
Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J Gastroenterol (2005) 0.88
Inhibitory effect of rosiglitazone on the acid-induced intracellular generation of hydrogen peroxide in cultured feline esophageal epithelial cells. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.86
Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids. World J Gastroenterol (2010) 0.81
Prevention by rebamipide of acute reflux esophagitis in rats. Dig Dis Sci (2005) 0.81
The resistance of esophageal adenocarcinoma to bile salt insult is associated with manganese superoxide dismutase expression. J Surg Res (2010) 0.79
Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats. Biomol Ther (Seoul) (2014) 0.78
Role of bile acids, prostaglandins and COX inhibitors in chronic esophagitis in a mouse model. World J Gastroenterol (2006) 0.78
Esophagitis impairs esophageal smooth muscle reactivity in the rat model: an in vitro study. Dig Dis Sci (2003) 0.78
From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma. World J Gastroenterol (2015) 0.77
Selection of patients with gastroesophageal reflux disease for antireflux surgery based on esophageal manometry. Dig Dis Sci (2003) 0.76
Protective effects of D-002 on experimentally induced gastroesophageal reflux in rats. World J Gastroenterol (2014) 0.76
Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease? World J Gastroenterol (2008) 0.76
NSAIDS, free radicals, and reflux esophagitis. Dig Dis Sci (1996) 0.75
The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. Gut Liver (2016) 0.75
Morphology and glycoconjugate content of opossum esophageal epithelium and glands: regional heterogeneity and effects of acid-induced mucosal injury and recovery. Dig Dis Sci (2005) 0.75
Oxidative mechanisms in the toxicity of metal ions. Free Radic Biol Med (1995) 6.90
Prevention of pancreatic cancer induction in hamsters by metformin. Gastroenterology (2001) 3.38
Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology (1985) 3.36
Laparoscopic Nissen fundoplication is an effective treatment for gastroesophageal reflux disease. Ann Surg (1994) 3.09
Distribution and release of human pancreatic polypeptide. Gut (1976) 3.02
Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol (1992) 2.96
Breast vs bottle: endocrine responses are different with formula feeding. Lancet (1980) 2.52
Ingested foreign bodies within the appendix: A 100-year review of the literature. Dig Dis (1999) 2.39
Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obes Metab (2004) 2.18
Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet (1976) 2.13
Neuropeptide Y distribution in the rat brain. Science (1983) 2.10
Five- to eight-year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg (2001) 2.03
Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy. Am J Surg (1977) 1.88
Suppression of pancreatic endocrine tumour secretion by long-acting somatostatin analogue. Lancet (1979) 1.81
Free radical scavengers prevent reflux esophagitis in rats. Dig Dis Sci (1995) 1.69
Is Barrett's metaplasia the source of adenocarcinomas of the cardia? Arch Surg (1994) 1.68
Mechanism of pancreatic polypeptide release in man. Lancet (1977) 1.68
Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut (1987) 1.68
Neuropeptide Y distribution in human brain. Nature (1984) 1.66
Bombesin: action on gut hormones and calcium in man. J Clin Endocrinol Metab (1982) 1.65
Laparoscopic Nissen fundoplication: where do we stand? Surg Laparosc Endosc (1997) 1.64
Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring. Ann Surg (1991) 1.58
Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int J Tissue React (2004) 1.51
Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg (1992) 1.50
Twenty-four-hour gastric luminal pH in normal subjects: influence of probe position, food, posture, and duodenogastric reflux. Am J Gastroenterol (1994) 1.48
The hypertensive lower esophageal sphincter. Am J Surg (1996) 1.45
The use of ultrasound to differentiate rectus sheath hematoma from other acute abdominal disorders. Surg Endosc (1999) 1.44
Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus. Surgery (1989) 1.44
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cells. Mol Cell Biochem (1999) 1.44
Laparoscopic paraesophageal hernia repair. Arch Surg (1997) 1.43
Surgical therapy in Barrett's esophagus. Ann Surg (1990) 1.43
Effect of calcitonin on gastrointestinal regulatory peptides in man. Clin Endocrinol (Oxf) (1985) 1.42
The effect of somatostatin analogs on secretion of growth, pancreatic, and gastrointestinal hormones in man. J Clin Endocrinol Metab (1981) 1.42
Plasma motilin, gastrin, and enteroglucagon and feeding in the human newborn. Arch Dis Child (1980) 1.42
Dissociation of pepsinogen and acid secretion in the guinea pig. Gastroenterology (1988) 1.40
Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39
A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39
Duodenoesophageal reflux and the development of esophageal adenocarcinoma in rats. Surgery (1992) 1.38
Canine gastric emptying of solids and liquids. Am J Physiol (1977) 1.37
Oxidative mechanisms in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol (2001) 1.36
Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med (2008) 1.36
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression. Pancreas (2000) 1.33
Management of ingested foreign bodies within the appendix: a case report with review of the literature. Am J Gastroenterol (1997) 1.33
Oxidative mechanisms in the toxicity of chromium and cadmium ions. J Environ Pathol Toxicol Oncol (2000) 1.32
Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology (1986) 1.32
Neuropeptide tyrosine (NPY)--a major cardiac neuropeptide. Lancet (1983) 1.31
Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg (1993) 1.25
The surgical option for gastroesophageal reflux disease. Am J Med (1997) 1.25
Reflux esophagitis in humans is mediated by oxygen-derived free radicals. Am J Surg (1995) 1.25
Laparoscopic Toupet fundoplication for gastroesophageal reflux disease with poor esophageal body motility. J Gastrointest Surg (2006) 1.24
Mechanisms and avoidance of esophageal perforation by anesthesia personnel during laparoscopic foregut surgery. Surg Endosc (1996) 1.23
Paraesophageal herniation as a complication following laparoscopic antireflux surgery. J Gastrointest Surg (2000) 1.21
Regulatory peptides in the mammalian respiratory tract. Endocrinology (1982) 1.21
Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia. Acta Paediatr Scand (1981) 1.20
Gut hormone release after intestinal resection. Gut (1982) 1.18
Effect of peptide YY on gastric, pancreatic, and biliary function in humans. Gastroenterology (1985) 1.18
Radioimmunoassay of neuropeptide Y. Regul Pept (1984) 1.18
Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines. Int J Pancreatol (1997) 1.17
Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol (1994) 1.17
Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem (2001) 1.16
Peptidergic innervation of the human male genital tract. J Urol (1983) 1.16
Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response? Gut (1985) 1.15
Distribution and immunocytochemical colocalization of peptide YY and enteroglucagon in endocrine cells of the rabbit colon. Endocrinology (1991) 1.15
Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology (1983) 1.14
Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med (1994) 1.14
Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses. Gut (1985) 1.14
Does delayed gastric emptying contribute to gastroesophageal reflux disease? Am J Surg (1989) 1.13
Effects of peptide YY and neuropeptide Y on gastric emptying in man. Digestion (1984) 1.13
Lipoxygenase inhibitors abolish proliferation of human pancreatic cancer cells. Biochem Biophys Res Commun (1999) 1.12
Free radical production in nicotine treated pancreatic tissue. Free Radic Biol Med (1995) 1.12
Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens. Neuropeptides (1982) 1.11
On the role of the islets of Langerhans in pancreatic cancer. Histol Histopathol (2004) 1.10
Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas. Diabetologia (1978) 1.10
Somatostatin and the dumping syndrome. Br Med J (Clin Res Ed) (1985) 1.10
Reflux esophagitis in humans is a free radical event. Dis Esophagus (1997) 1.09
Management of the failed antireflux operation. Surg Clin North Am (1997) 1.09
Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusion-induced activation of JNK-1 and C-JUN. Free Radic Biol Med (2001) 1.09
Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol (2001) 1.08
Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas. Histochemistry (1984) 1.07
Gastric mucosal injury caused by hemorrhagic shock and reperfusion: protective role of the antioxidant glutathione. Surgery (1990) 1.06
Cardioprotective effects of grape seed proanthocyanidin against ischemic reperfusion injury. J Mol Cell Cardiol (1999) 1.06
Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas (1997) 1.06
Review of the apoptosis pathways in pancreatic cancer and the anti-apoptotic effects of the novel sea cucumber compound, Frondoside A. Ann N Y Acad Sci (2008) 1.06
Heller myotomy is superior to dilatation for the treatment of early achalasia. Arch Surg (1997) 1.06
Pancreatic tumours produce neurotensin. J Clin Endocrinol Metab (1981) 1.05